News
Release of Eliquis blood clot preventer story | Reuters
www.reuters.com
The blood clot preventer Eliquis, sold by Pfizer Inc and Bristol-Myers Squibb Co, proved as effective as widely used warfarin in treating a dangerous condition...
PROFILAXIS DEL TROMBOEMBOLISMO VENOSO EN EL PACIENTE ONCOLÓGICO...
www.seom.org
PROFILAXIS DEL TROMBOEMBOLISMO VENOSO EN EL PACIENTE ONCOLÓGICO AMBULATORIO Y ... Giancarlo Agnelli, University of Perugia, Perugia, Italy; Daniel George,
Apixaban appears safe, effective for patients with cancer, VTE
www.healio.com
“Patients with cancer are prone to developing VTE,” Giancarlo Agnelli, MD, professor of internal medicine and director of the division of internal ...
Good news for apixaban in recurrent VTE prevention | Clinical...
www.mdedge.com
The number needed to treat with apixaban (Eliquis) to prevent one fatal or nonfatal recurrent VTE was only 14, while the number needed to treat to cause one episode of major or clinically relevant nonmajor bleeding was 200, Dr. Giancarlo Agnelli reported in a late-breaking abstract at the annual meeting ...
sortiert nach Relevanz / Datum